Protective bacteria in the infant gut have resourceful way of helping babies break down breast milk

August 13, 2012 by Danielle Gutierrez

A research team at the University of California, Davis, has found that important and resourceful bacteria in the baby microbiome can ferret out nourishment from a previously unknown source, possibly helping at-risk infants break down components of breast milk.

Breast milk is amazingly intricate, providing all of the necessary to sustain and strengthen infants in the first months of life. Moreover, this of nutrition provides protection from infections, allergies and many other illnesses.

Breast milk also promotes the growth of protective bacteria in an infant's intestine. Because breast milk contains glycans (complex sugars) that infants cannot breakdown, it promotes the growth a specific type of bacteria, called bifidobacteria, that can process these glycans. While it is known that bifidobacteria avail themselves of the free glycans in breast milk, it was not known whether these bacteria could also obtain glycans that were linked to proteins. Such proteins are called glycoproteins, and they are abundant in breast milk.

The research team led by David A. Mills at the UC-Davis investigated the ability of bifidobacteria to remove glycans from milk glycoproteins. Their work was recently published in the journal Molecular & Cellular Proteomics.

Mills' group found that specific strains of bifidobacteria possessed enzymes capable of removing glycan groups from glycoproteins, enabling them to use these glycans as an additional food source. Surprisingly, one of the enzymes, EndoBI-1, was able to remove any type of N-linked glycan (glycans attached to proteins by the amino acid asparagine). This is unique among enzymes of this type and may provide a growth advantage for bifidobacteria in the infant because the glycoproteins in have complex glycans attached.

Mills explains that the ability of EndBI-1 to remove a variety of complex N-linked glycans combined with its unusual heat stability make "this potentially a very useful tool in both food processing and proteomics/pharmaceutical research."

The team's work suggests that bifidobacteria do not primarily feed on the glycans from milk glycoproteins. However, the study did show that under the proper conditions bidfidobacteria can grow when -linked glycans are the only energy source.

"One obvious goal of this research is to find ways to translate the benefits provided by milk and to at risk populations such as premature infants, malnourished children, among many others," Mills says.

Explore further: New method of bacterial cell engineering can produce better, cheaper drug therapies

More information: "Endo-β-N-acetylglucosaminidases from infant-gut associated bifidobacteria release complex N-glycans from human milk glycoproteins" by Daniel Garrido, Charles Nwosu, Santiago Ruiz-Moyano, Danielle Aldredge, J. Bruce German, Carlito B. Lebrilla and David A. Mills.

Related Stories

New method of bacterial cell engineering can produce better, cheaper drug therapies

March 26, 2012
(PhysOrg.com) -- Escherichia coli – a bacteria considered the food safety bane of restaurateurs, grocers and consumers – is a friend. Cornell University biomolecular engineers have learned to use E. coli to produce ...

Recommended for you

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.